-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How Do We Effectively Capture Adverse Events, Particularly Infections Post Hematopoietic Stem Cell Transplantation?

Symposia: Scientific Workshop on Genomic Toxicities of Gene and Cell Therapies Program: Scientific Workshops
Friday, December 6, 2024: 4:14 PM-4:53 PM
Room 31 (San Diego Convention Center)
Moderators:
Matthew Hsieh, MD, NIH-NHLBI-MCHB and Rayne Rouce, MD, Clinical Care Center-Texas Children's Hospital
Disclosures:
Rouce: Pfizer: Consultancy; Novartis: Honoraria.

We will conclude with a discussion focused on the benefits and limitations of current systems of adverse event monitoring, with the aim of engaging regulatory agencies to design more effective approaches.

Matthew Hsieh, MD

NHLBI, NIH-NHLBI-MCHB, Bethesda, MD

Rayne Rouce, MD

Clinical Care Center-Texas Children's Hospital, Houston, TX

Adetola A. Kassim, MBBS, MS

Vanderbilt University Medical Center, Nashville, TN

Kathryn Cappell, MD, PhD

National Institutes of Health, Bethesda, MD